An oily climate deal
Semafor’s Tim McDonnell says what made COP28 successful was the same thing that made climate activists skeptical about the conference: its host was an oil executive. This episode was produced by Victo...
14 Des 202326min
Long live your dog
A drug that aims to increase life expectancy for dogs is getting closer to market. But pet ethicists aren’t sure it’s great news for man’s best friend. This episode was produced by Amanda Lewellyn, ed...
13 Des 202325min
The fight over campus antisemitism
Three elite university presidents walk into Congress for a hearing on antisemitism. Only two still have their jobs. New York magazine reporter Nia Prater tells us what happened, and a Harvard professo...
12 Des 202325min
A concrete solution to climate change
Concrete is one of the world’s biggest sources of carbon emissions. Tech companies, including a startup co-founded by former NBA star Rick Fox, are looking to change that. This episode was produced by...
11 Des 202325min
Are movies too long now?
No, movies aren’t getting longer. Even though, yes, it definitely does feel like they are. Slate’s Sam Adams makes it make sense. This episode was produced by Victoria Chamberlin, edited by Matt Colle...
8 Des 202325min
Get the lead out
The Biden administration wants all lead pipes ripped up. It’ll take billions of dollars and rarely seen cooperation among government agencies. We ask UC Berkeley’s David Sedlak and American University...
7 Des 202325min
Still hot and bothered
Earlier this year the FDA approved a game-changing drug to treat hot flashes, a symptom of menopause. But menopause is much more than just hot flashes, as health writer Jancee Dunn explains. We talked...
6 Des 202325min
They paved paradise
In our quest to accommodate parked cars, we’ve paved over downtowns, polluted the planet, and made it damn near impossible to get anywhere without driving. In May we talked to Slate’s Henry Grabar, wh...
5 Des 202325min
